|
1.
|
Othman MO and Wallace MB: Endoscopic
mucosal resection (EMR) and endoscopic submucosal dissection (ESD)
in 2011, a Western perspective. Clin Res Hepatol Gastroenterol.
35:288–294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Fujishiro M: Perspective on the practical
indications of endoscopic submucosal dissection of gastrointestinal
neoplasms. World J Gastroenterol. 14:4289–4295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kim SH, Moon JS, Youn YH, Lee KM and Lee
SJ: Management of the complications of endoscopic submucosal
dissection. World J Gastroenterol. 17:3575–3579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Oda I, Saito D, Tada M, et al: A
multicenter retrospective study of endoscopic resection for early
gastric cancer. Gastric Cancer. 9:262–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Isomoto H, Shikuwa S, Yamaguchi N, et al:
Endoscopic submucosal dissection for early gastric cancer: a
large-scale feasibility study. Gut. 58:331–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Abe N, Takeuchi H, Ohki A, et al:
Long-term outcomes of combination of endoscopic submucosal
dissection and laparoscopic lymph node dissection without
gastrectomy for early gastric cancer patients who have a potential
risk of lymph node metastasis. Gastrointest Endosc. 74:792–797.
2011. View Article : Google Scholar
|
|
7.
|
Chung IK, Lee JH, Lee SH, et al:
Therapeutic outcomes in 1000 cases of endoscopic submucosal
dissection for early gastric neoplasms: Korean ESD Study Group
multicenter study. Gastrointest Endosc. 69:1228–1235. 2009.
View Article : Google Scholar
|
|
8.
|
Daneshmend TK, Hawkey CJ, Langman MJ,
Logan RF, Long RG and Walt RP: Omeprazole versus placebo for acute
upper gastrointestinal bleeding: randomised double blind controlled
trial. BMJ. 304:143–147. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Lee SH, Lee CK, Chung IK, et al: Optimal
duration of proton pump inhibitor in the treatment of endoscopic
submucosal dissection-induced ulcers: a retrospective analysis and
prospective validation study. Dig Dis Sci. 57:429–434. 2012.
View Article : Google Scholar
|
|
10.
|
Tominaga K, Iwakiri R, Fujimoto K, et al
GERD 4 Study Group: Rikkunshito improves symptoms in PPI-refractory
GERD patients: a prospective, randomized, multicenter trial in
Japan. J Gastroenterol. 47:284–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tatsuta M and Iishi H: Effect of treatment
with liu-jun-zi-tang (TJ-43) on gastric emptying and
gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol
Ther. 7:459–462. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Seike J, Sawada T, Kawakita N, et al: A
new candidate supporting drug, rikkunshito, for the QOL in advanced
esophageal cancer patients with chemotherapy using
docetaxel/5-FU/CDDP. Int J Surg Oncol. 2011:7156232011.PubMed/NCBI
|
|
13.
|
Hayakawa T, Arakawa T, Kase Y, et al:
Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in
isolated guinea pig stomachs. Drugs Exp Clin Res. 25:211–218.
1999.PubMed/NCBI
|
|
14.
|
Mochiki E, Yanai M, Ohno T and Kuwano H:
The effect of traditional Japanese medicine (Kampo) on
gastrointestinal function. Surg Today. 40:1105–1111.
2010.PubMed/NCBI
|
|
15.
|
Revicki DA, Wood M, Wiklund I and Crawley
J: Reliability and validity of the Gastrointestinal Symptom Rating
Scale in patients with gastroesophageal reflux disease. Qual Life
Res. 7:75–83. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sanaka M and Nakata K: Stable isotope
breath tests for assessing gastric emptying: A comprehensive
review. J Smooth Muscle Res. 46:267–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma - 2nd English edition.
Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Parkman HP and Jones MP: Tests of gastric
neuromuscular function. Gastroenterology. 136:1526–1543. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kelly KA: Gastric emptying of liquids and
solids: roles of proximal and distal stomach. Am J Physiol.
239:G71–G76. 1980.PubMed/NCBI
|
|
21.
|
Camilleri M, Malagelada JR, Brown ML,
Becker G and Zinsmeister AR: Relation between antral motility and
gastric emptying of solids and liquids in humans. Am J Physiol.
249:G580–G585. 1985.PubMed/NCBI
|
|
22.
|
Tieerdsma HC, Smout AJ and Akkermans LM:
Voluntary suppression of defecation delays gastric emptying. Dig
Dis Sci. 38:832–836. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lee OY: Asian motility studies in
irritable bowel syndrome. J Neurogastroenterol Motil. 16:120–130.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hattori T: Rikkunshito and ghrelin. Int J
Pept. 2010:2835492010. View Article : Google Scholar
|
|
25.
|
Kusunoki H, Haruma K, Hata J, et al:
Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo),
in treating functional dyspepsia. Intern Med. 49:2195–2202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Takahashi T, Endo S, Nakajima K, Souma Y
and Nishida T: Effect of rikkunshito, a Chinese herbal medicine, on
stasis in patients after pylorus-preserving gastrectomy. World J
Surg. 33:296–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Kido T, Nakai Y, Kase Y, et al: Effects of
rikkunshi-to, a traditional Japanese medicine, on the delay of
gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci.
98:161–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Takeda H, Sadakane C, Hattori T, et al:
Rikkunshito, an herbal medicine, suppresses cisplatin-induced
anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology.
134:2004–2013. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Matsumura T, Arai M, Yonemitsu Y, et al:
The traditional Japanese medicine Rikkunshito increases the plasma
level of ghrelin in humans and mice. J Gastroenterol. 45:300–307.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Arai M, Matsumura T, Tsuchiya N, et al:
Rikkunshito improves the symptoms in patients with functional
dyspepsia, accompanied by an increase in the level of plasma
ghrelin. Hepatogastroenterology. 59:62–66. 2012.PubMed/NCBI
|
|
31.
|
Arakawa T, Higuchi K, Fujiwara Y, et al:
Gastroprotection by Liu-Jun-Zi-Tang (TJ-43): possible mediation of
nitric oxide but not prostaglandins or sulfhydryls. Drugs Exp Clin
Res. 25:207–210. 1999.PubMed/NCBI
|
|
32.
|
Nakai Y, Kido T, Hashimoto K, et al:
Effect of the rhizomes of Atractylodes lancea and its
constituents on the delay of gastric emptying. J Ethnopharmacol.
84:51–55. 2003.
|
|
33.
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
van der Lely AJ, Tschöp M, Heiman ML and
Ghigo E: Biological, physiological, pathophysiological, and
pharmacological aspects of ghrelin. Endocr Rev. 25:426–457.
2004.PubMed/NCBI
|
|
35.
|
Konturek PC, Brzozowski T, Pajdo R, et al:
Ghrelin - a new gastroprotective factor in gastric mucosa. J
Physiol Pharmacol. 55:325–336. 2004.PubMed/NCBI
|
|
36.
|
Fujitsuka N, Asakawa A, Uezono Y, et al:
Potentiation of ghrelin signaling attenuates cancer
anorexia-cachexia and prolongs survival. Transl Psychiatry.
26:e232011. View Article : Google Scholar : PubMed/NCBI
|
